APA (7th ed.) Citation

N, I., N, H., T, T., Y, T., R, M., S, I., . . . H, M. (2025). Efficacy and Safety of Intravenous-to-Oral Lascufloxacin Switch Therapy in Community-Onset Pneumonia: A Single-Arm, Open-Label Clinical Trial. Cureus, 17(3), e80404. https://doi.org/10.7759/cureus.80404

Chicago Style (17th ed.) Citation

N, Iwanaga, et al. "Efficacy and Safety of Intravenous-to-Oral Lascufloxacin Switch Therapy in Community-Onset Pneumonia: A Single-Arm, Open-Label Clinical Trial." Cureus 17, no. 3 (2025): e80404. https://doi.org/10.7759/cureus.80404.

MLA (9th ed.) Citation

N, Iwanaga, et al. "Efficacy and Safety of Intravenous-to-Oral Lascufloxacin Switch Therapy in Community-Onset Pneumonia: A Single-Arm, Open-Label Clinical Trial." Cureus, vol. 17, no. 3, 2025, p. e80404, https://doi.org/10.7759/cureus.80404.